MA28842B1 - 1(indole-6-carbonyl-d-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine d-tartrate - Google Patents
1(indole-6-carbonyl-d-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine d-tartrateInfo
- Publication number
- MA28842B1 MA28842B1 MA29641A MA29641A MA28842B1 MA 28842 B1 MA28842 B1 MA 28842B1 MA 29641 A MA29641 A MA 29641A MA 29641 A MA29641 A MA 29641A MA 28842 B1 MA28842 B1 MA 28842B1
- Authority
- MA
- Morocco
- Prior art keywords
- phenylglycinyl
- methylpiperidin
- indole
- tartrate
- piperazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58359904P | 2004-06-30 | 2004-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA28842B1 true MA28842B1 (fr) | 2007-09-03 |
Family
ID=35276192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29641A MA28842B1 (fr) | 2004-06-30 | 2007-01-29 | 1(indole-6-carbonyl-d-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine d-tartrate |
Country Status (19)
Country | Link |
---|---|
US (1) | US20070249623A1 (fr) |
EP (1) | EP1763521A1 (fr) |
JP (1) | JP2008505075A (fr) |
CN (1) | CN1984903A (fr) |
AR (1) | AR049659A1 (fr) |
AU (1) | AU2005267579A1 (fr) |
BR (1) | BRPI0512245A (fr) |
CA (1) | CA2570634A1 (fr) |
EA (1) | EA010307B1 (fr) |
EC (1) | ECSP067105A (fr) |
IL (1) | IL179903A0 (fr) |
MA (1) | MA28842B1 (fr) |
MX (1) | MXPA06015112A (fr) |
NO (1) | NO20070486L (fr) |
PE (1) | PE20060480A1 (fr) |
SV (1) | SV2006002156A (fr) |
TW (1) | TW200603806A (fr) |
WO (1) | WO2006011955A1 (fr) |
ZA (1) | ZA200610091B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0616574D0 (en) * | 2006-08-21 | 2006-09-27 | Glaxo Group Ltd | Compounds |
CN107365304A (zh) * | 2017-08-01 | 2017-11-21 | 齐宜涛 | 一种治疗心血管疾病的化合物及制备方法和应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA51676C2 (uk) * | 1995-11-02 | 2002-12-16 | Пфайзер Інк. | (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція |
GB9821058D0 (en) * | 1998-09-28 | 1998-11-18 | Univ Cardiff | Chemical compound |
DE60022742D1 (de) * | 1999-03-15 | 2006-02-02 | Novo Nordisk As | Salz des (2r,3r,4r)-3,4-dihydroxy-2-hydroxmethylpyrrolidins |
CA2375920A1 (fr) * | 1999-06-14 | 2000-12-21 | Eli Lilly And Company | Composes |
US6448293B1 (en) * | 2000-03-31 | 2002-09-10 | Pfizer Inc. | Diphenyl ether compounds useful in therapy |
GB0030304D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
GB0019228D0 (en) * | 2000-08-04 | 2000-09-27 | Smithkline Beecham Plc | Novel pharmaceutical |
SK287170B6 (sk) * | 2001-05-14 | 2010-02-08 | Pfizer Products Inc. | Tartrátová soľ 5,8,14-triazatetracyklo-[10.3.1.02,11.04,9]- hexadeka-2(11),3,5,7,9-pentaénu, jej použitie a farmaceutická kompozícia s jej obsahom |
TWI257389B (en) * | 2001-06-12 | 2006-07-01 | Lilly Co Eli | Pharmaceutical compound |
-
2005
- 2005-06-13 WO PCT/US2005/020490 patent/WO2006011955A1/fr active Application Filing
- 2005-06-13 BR BRPI0512245-7A patent/BRPI0512245A/pt not_active IP Right Cessation
- 2005-06-13 US US11/570,686 patent/US20070249623A1/en not_active Abandoned
- 2005-06-13 CA CA002570634A patent/CA2570634A1/fr not_active Abandoned
- 2005-06-13 CN CNA2005800214090A patent/CN1984903A/zh active Pending
- 2005-06-13 MX MXPA06015112A patent/MXPA06015112A/es not_active Application Discontinuation
- 2005-06-13 EA EA200700186A patent/EA010307B1/ru not_active IP Right Cessation
- 2005-06-13 AU AU2005267579A patent/AU2005267579A1/en not_active Abandoned
- 2005-06-13 JP JP2007519246A patent/JP2008505075A/ja active Pending
- 2005-06-13 EP EP05760368A patent/EP1763521A1/fr not_active Withdrawn
- 2005-06-17 TW TW094120115A patent/TW200603806A/zh unknown
- 2005-06-27 PE PE2005000741A patent/PE20060480A1/es not_active Application Discontinuation
- 2005-06-29 AR ARP050102705A patent/AR049659A1/es unknown
- 2005-06-29 SV SV2005002156A patent/SV2006002156A/es not_active Application Discontinuation
-
2006
- 2006-12-01 ZA ZA200610091A patent/ZA200610091B/en unknown
- 2006-12-07 IL IL179903A patent/IL179903A0/en unknown
- 2006-12-20 EC EC2006007105A patent/ECSP067105A/es unknown
-
2007
- 2007-01-25 NO NO20070486A patent/NO20070486L/no not_active Application Discontinuation
- 2007-01-29 MA MA29641A patent/MA28842B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
NO20070486L (no) | 2007-01-25 |
AU2005267579A1 (en) | 2006-02-02 |
EP1763521A1 (fr) | 2007-03-21 |
WO2006011955A1 (fr) | 2006-02-02 |
ECSP067105A (es) | 2007-01-26 |
US20070249623A1 (en) | 2007-10-25 |
EA200700186A1 (ru) | 2007-06-29 |
PE20060480A1 (es) | 2006-07-13 |
IL179903A0 (en) | 2007-05-15 |
ZA200610091B (en) | 2008-02-27 |
EA010307B1 (ru) | 2008-08-29 |
AR049659A1 (es) | 2006-08-23 |
CA2570634A1 (fr) | 2006-02-02 |
JP2008505075A (ja) | 2008-02-21 |
BRPI0512245A (pt) | 2008-02-19 |
MXPA06015112A (es) | 2007-02-08 |
SV2006002156A (es) | 2006-02-15 |
TW200603806A (en) | 2006-02-01 |
CN1984903A (zh) | 2007-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE414698T1 (de) | Durch 5gliedrige heterocyclen substituierte mtp- inhibierende arylpiperidine oder -piperazine | |
BRPI0511900A (pt) | composições farmacêuticas | |
DK2783682T3 (da) | Farmaceutisk sammensætning omfattende pimobendan | |
ITMI20041252A1 (it) | Composizioni perfluoroelastomeriche | |
FR2862654B1 (fr) | Composition amylacee filmogene | |
DE602005020716D1 (de) | Fluoroelastomere | |
FR2888505B1 (fr) | Nouvelles compositions cosmetiques amincissantes | |
HK1095327A1 (en) | 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists | |
ATE483497T1 (de) | Mundpflegezusammensetzungen | |
DE602005016978D1 (de) | Quecksilberfreisetzende Zusammensetzungen | |
DK1587478T3 (da) | Farmaceutisk sammensætning | |
MA28801B1 (fr) | Composition antihistaminique | |
DK1704213T3 (da) | Petroleumpræparat | |
DE602004000946D1 (de) | Dimethylpolysiloxan -Zusammensetzung | |
DE60230491D1 (de) | Als ccr5-antagonisten verwendbare aryloxim-piperazine | |
DE602005023511D1 (de) | Metall-isolator-metall-bauelement | |
MA28842B1 (fr) | 1(indole-6-carbonyl-d-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine d-tartrate | |
ITMI20040943A1 (it) | Composizione farmaceutica cicatrizzante | |
NO20042027L (no) | Oral composition | |
ITRE20040074A1 (it) | "profumatore per ambienti" | |
GB0415129D0 (en) | Care composition | |
UA11067S (uk) | Диван-ліжко «акварель» | |
UA13381S (uk) | Стіл «япі» | |
SE0402473D0 (sv) | Cravel (krypstrumpbyxan) | |
ITBA20040021A1 (it) | Sdrv1 - sistema di disimpilazione rapida - versione 1 |